Kishor Wasan, PhD, FAAPS, FCAHS, FCSPS

Distinguished Canadian Professor at the University of British Columbia

Dr. Kishor M. Wasan is a Canadian pharmacologist, pharmacist and professor. He was the dean and professor (retired) of the University of Saskatchewan's College of Pharmacy and Nutrition from 2014 to 2019 and associate dean of research and graduate studies as well as a full professor at the Faculty of Pharmaceutical Sciences at the University of British Columbia (UBC) from 2011 to 2014. Previously at UBC, he was chair of pharmaceutics and national director of the Canadian Summer Student Research Program after first joining the faculty in 1995. Wasan's research focuses on lipid-based drug delivery and the interaction between lipoprotein and pharmaceuticals. He has published more than 550 peer-reviewed articles and abstracts. He has a Public Leadership Credential from Harvard Kennedy School 2021. He is a founding member and currently co-director of UBC's Neglected Global Diseases Initiative and an distinguished university scholar adjunct professor in the Department of Urologic Sciences in the Faculty of Medicine at UBC. Dr. Wasan has received numerous awards (over 25) for his contributions to health sciences and is currently a fellow of the Canadian Academy of Health Sciences (one of the highest honors in Canada), the Canadian Society for Pharmaceutical Sciences and the American Association of Pharmaceutical Scientists, a fellow member of the Royal Society of Medicine (London, UK) and an elected member of the Sigma Xi Scientific Research Honor Society. He is the co-inventor of a novel oral amphotericin B formulation to treat leishmaniasis and systemic fungal infections that is cost-effective, safe, tropically stable, accessible and with positive human phase 1 safety data. Under the Global Access and Equity Principles at UBC this product will be provided to all those in need at or below development costs with no profit will be taken for this product.